Arterra Bioscience
ARBS.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €4,173 | €3,336 | €3,591 | €4,742 |
| % Growth | 25.1% | -7.1% | -24.3% | – |
| Cost of Goods Sold | €523 | €1,486 | €3,071 | €3,152 |
| Gross Profit | €3,650 | €1,850 | €493 | €673 |
| % Margin | 87.5% | 55.5% | 13.7% | 14.2% |
| R&D Expenses | €1,991 | €0 | €1,638 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €162 | €1,769 | €107 | €172 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €29 | -€1,602 | -€1,617 | €18 |
| Operating Expenses | €2,181 | €166 | €128 | €190 |
| Operating Income | €1,469 | -€356 | €365 | €1,919 |
| % Margin | 35.2% | -10.7% | 10.2% | 40.5% |
| Other Income/Exp. Net | €233 | €1,659 | €1,432 | -€648 |
| Pre-Tax Income | €1,701 | €1,302 | €1,797 | €1,271 |
| Tax Expense | €365 | €226 | €383 | €163 |
| Net Income | €1,337 | €1,076 | €1,414 | €1,111 |
| % Margin | 32% | 32.3% | 39.4% | 23.4% |
| EPS | 0.2 | 0.16 | 0.21 | 0.17 |
| % Growth | 25% | -23.8% | 23.5% | – |
| EPS Diluted | 0.2 | 0.16 | 0.21 | 0.17 |
| Weighted Avg Shares Out | 6,658 | 6,658 | 6,658 | 6,658 |
| Weighted Avg Shares Out Dil | 6,658 | 6,658 | 6,658 | 6,658 |
| Supplemental Information | – | – | – | – |
| Interest Income | €130 | €93 | €201 | €3 |
| Interest Expense | €1 | €10 | €8 | €8 |
| Depreciation & Amortization | €339 | €532 | €532 | €487 |
| EBITDA | €2,042 | €1,844 | €2,337 | €1,767 |
| % Margin | 48.9% | 55.3% | 65.1% | 37.3% |